Vitamin D status in men with psoriatic arthritis: a case-control study

Osteoporosis International

Volumn 26, Issue 7, 2015, Pages 1965-1970

  Petho, Z ^a   Kulcsar Jakab, E ^a   Kalina, E ^a   Balogh, A ^a   Pusztai, A ^a   Gulyas, K ^a   Horvath, A ^a   Szekanecz, Z ^a   Bhattoa, H P ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Bone markers; Bone mineral density; Men; Psoriatic arthritis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; OSTEOCALCIN; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARATHYROID GLAND; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SKIN DEFECT; VITAMIN DEFICIENCY; ANALOGS AND DERIVATIVES; ARTHRITIS, PSORIATIC; BLOOD; CASE CONTROL STUDY; COMPLICATION; HUNGARY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; BONE DENSITY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; HUNGARY; MALE; MIDDLE AGED; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84933277648     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3069-2     Document Type: Article

References (38)

1. Myers WA, Gottlieb AB, Mease P (2006) Psoriasis and psoriatic arthritis: clinical features and disease mechanisms. Clin Dermatol 24:438–447
2. Leonard DG, O’Duffy JD, Rogers RS (1978) Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis. Mayo Clin Proc 53:511–508
3. Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE (2000) The epidemiology of psoriatic arthritis in Olmstead County, Minnesota, USA, 1982–1991. J Rheumatol 27:1247–1250
4. Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450–456
5. Ferrandiz C, Pujol RM, Garcia-Patos V, Bordas X, Smandia JA (2002) Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 46:867–873
6. McHugh NJ, Balachrishnan C, Jones SM (2003) Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 42:778–783
7. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573
8. Gladman D, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64:ii14–ii17
9. Mease PJ, Goffe BS (2005) Diagnosis and treatment of psoriatic arthritis. J Am Acad Dermatol 52:1–19
10. Omdahl JL, Garry PJ, Hunsaker LA, Hunt WC, Goodwin JS (1982) Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr 36:1225–1233
11. Khaw KT, Sneyd MJ, Compston J (1992) Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 305:273–277
12. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM (1995) Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10:1177–1784
13. McAuley KA, Jones S, Lewis-Barned NJ, Manning P, Goulding A (1997) Low vitamin D status is common among elderly Dunedin women. N Z Med J 110:275–277
14. Stumpf WE, Sar M, Clark SA, DeLuca HF (1982) Brain target sites for 1,25-dihydroxyvitamin D3. Science 215:1403–1405
15. Clemens TL, Garrett KP, Zhou XY, Pike JW, Haussler MR, Dempster DW (1988) Immunocytochemical localization of the 1,25-dihydroxyvitamin-D3 receptor in target cells. Endocrinology 122:1224–1230
16. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325–349
17. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M (2001) Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888–894
18. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308–1310
19. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181–1183
20. Huckins D, Felson DT, Holick M (1990) Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study. Arthritis Rheum 33:1723–1727
21. Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J, Chevrant-Breton J, Beylot C, Bazex JA, Jurgensen HJ (1992) Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris: a randomized, double-blind, right/left comparative, vehicle-controlled study. J Am Acad Dermatol 27:983–988
22. Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662–687
23. Nieves J, Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687–1692
24. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa women’s health study. Arthritis Rheum 50:72–77
25. Devaraj S, Yun JM, Duncan-Staley CR, Jialal I (2011) Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am J Clin Pathol 135:429–433
26. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716
27. Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244
28. Prevoo ML, Van’t Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48
29. Bhattoa HP, Nagy E, More C, Kappelmayer J, Balogh A, Kalina E, Antal-Szalmas P (2013) Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age. The HunMen study. Osteoporos Int 24:179–186
30. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673
31. Orgaz-Molina J, Buendía-Eisman CA, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S (2012) Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol 67:931–938
32. Orgaz-Molina J, Magro-Checa C, Rosales-Alexander JL, Arrabal-Polo MA, Buendía-Eisman A, Raya-Alvarez E, Arias-Santiago S (2013) Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis. J Am Acad Dermatol 69:938–946
33. Del Puente A, Esposito A, Parisi A, Atteno M, Montalbano S, Vitiello M, Esposito C, Bertolini N, Foglia F, Costa L, Scarpa R (2012) Osteoporosis and psoriatic arthritis. J Rheumatol 89:36–38
34. Borman P, Babaoglu S, Gur G, Bingol S, Bodur H (2008) Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol 27:443–447
35. Attia EA, Khafagy A, Abdel-Raheem S, Fathi S, Saad AA (2011) Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. Int J Dermatol 50:30–35
36. Frediani B, Allegri A, Falsetti P, Storri L, Bisogno S, Baldi F, Filipponi P, Marcolongo R (2001) Bone mineral density in patients with psoriatic arthritis. J Rheumatol 28:138–143
37. Pedreira PG, Pinheiro MM, Szejnfeld VL (2011) Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 13:R16
38. Holick MF (1994) Vitamin D—new horizons for the 21st century. Am J Clin Nutr 60:619–630